Page last updated: 2024-10-28

ha14-1 and Astrocytoma, Grade IV

ha14-1 has been researched along with Astrocytoma, Grade IV in 1 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Research Excerpts

ExcerptRelevanceReference
" We show here that ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA14-1), a small organic compound recently proposed to function as an inhibitor of Bcl-2, increases the sensitivity of human glioblastoma cells to radiotherapy and chemotherapy."3.73The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. ( Cartron, PF; Cauquil, N; Gallenne, T; Gautier, F; Geneste, O; Grée, D; Grée, R; Juin, P; Manero, F; Vallette, FM, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manero, F1
Gautier, F1
Gallenne, T1
Cauquil, N1
Grée, D1
Cartron, PF1
Geneste, O1
Grée, R1
Vallette, FM1
Juin, P1

Other Studies

1 other study available for ha14-1 and Astrocytoma, Grade IV

ArticleYear
The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death.
    Cancer research, 2006, Mar-01, Volume: 66, Issue:5

    Topics: Amino Acid Sequence; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Assoc

2006